Scholars Central

Research articlePublished 26 Feb 2018

Serum levels of advanced glycation end products in type II diabetic patients with acute cerebral infarction

Authors: Hao Ju, Qingshi Zhao, Wei Li, Haiyan Liu, Yan Gao, Lin Yi, Hongyan Wang, Zhaohui Wang, Chuan Liu, Fanhua Meng, Haiping Li, Ligang Jiang

Biomedical Research

Volume 29 · Issue 3 · Pages 544–548

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Advanced glycation end products (AGEs) are reported to be associated with diabetic vascular complications. However, the role of AGEs in the pathogenesis of cerebral thrombosis remains unclear. This study aimed to investigate the relationship between advanced glycation end products (AGEs) generation and pathogenesis of cerebral thrombosis. Methods: 100 patients with cerebral thrombosis were recruited and 50 healthy controlled individuals were served as a control group. Enzyme Linked Immunosorbent Assay (ELISA) was applied for measuring serum AGEs level. The condition of carotid intima was examined by carotid ultrasonography. Serum AGEs levels were compared among patients with certain conditions of carotid atherosclerosis. Results: AGEs levels in carotid plaque or thickening groups showed significant difference compared with those in control group. Carotid plaque patients showed remarkably different AGEs levels compared to thickening patients. AGEs levels were significantly elevated with higher severity of carotid plaque. Moderate or severe stenosis patients, or blocked group showed significantly different AGEs compared to mild stenosis group. Severe stenosis or blockade group showed remarkably different AGEs compared with moderate stenosis patients. In addition, severe stenosis group had statistically different AGEs compared with blockade group. Conclusion: AGEs level is correlated with pathogenesis of cerebral thrombosis and they are further elevated with aggravation of carotid atherosclerosis in patients, suggesting they might be used as a biomarker to evaluate the severity of atherosclerosis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Biomedical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomedical Research
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Hao Ju”
  • BylineArticles whose byline prints “Qingshi Zhao”
  • BylineArticles whose byline prints “Wei Li”
  • BylineArticles whose byline prints “Haiyan Liu”
  • BylineArticles whose byline prints “Yan Gao”
  • BylineArticles whose byline prints “Lin Yi”
  • BylineArticles whose byline prints “Hongyan Wang”
  • BylineArticles whose byline prints “Zhaohui Wang”